Rob Dillard

DocwireNews

DocWire News&nbsp;recently spoke with Dr. Shaun Grannis, Vice President, Data and Analytics, Regenstrief Institute, to discuss the importance of medical informatics amid the ongoing COVID-19 pandemic, and how data and analytics are being used to track the virus. See what he had to say.DocWire News: Can you tell us what the Regenstrief Institute does, particularly as it relates to COVID-19?Dr. Shaun Grannis: Sure. Absolutely. So, the Regenstrief Institute was founded about over 50 years ago now by a process engineer who had a suboptimal experience with the healthcare system. And he said, &ldquo;If I ran my company like hospitals run their systems, I&rsquo;d be bankrupt.&rdquo; So, he committed to bringing process engineering and technology to medicine. So, the Institute has been doing a lot of work in the field of medical informatics and health services research to improve healthcare and healthcare delivery.That informatics component has led us to build electronic health record systems, health information exchange technology, a variety of artifacts for the health IT space. When it comes to the COVID crisis, we were able to help support our state&rsquo;s response to COVID in that we had built an infrastructure for the state to identify notifiable diseases, and deliver COVID related data to the state very quickly. And so, we are a medical informatics and health services research think tank, providing insight, guidance, conducting research and innovation. And have been doing so for over 50 years now.DocWire News:&nbsp;Looking at the data in the US, where do you believe we are currently in the pandemic? Are we on the right track, or are there still some pitfalls ahead?Dr. Shaun Grannis: Well, we&rsquo;re monitoring the data very closely. And, certainly, we&rsquo;ve seen since late 2020, we&rsquo;ve seen a general gradual decrease in the number of new cases, which I think is excellent. We also, for the state of Indiana, we&rsquo;re tracking hospitalizations, emergency department visits, the use of the ICU and even deaths. And all of those numbers are heading in the right direction. So, nationally numbers appear to be heading in the right direction, and in the State of Indiana where we monitor closely, we see things heading in the right direction.Now, that doesn&rsquo;t mean we should rest on our laurels. I think we need to continue to be vigilant. I think we need to continue to monitor what&rsquo;s happening because the COVID virus has surprised us at quite a few junctures throughout the pandemic. So, we&rsquo;re heading in the right direction. And I think that&rsquo;s very encouraging.DocWire News: How important have analytics and the flow of information been amid the pandemic?Dr. Shaun Grannis: Well, I think data has been the lifeblood of decision-making for the pandemic. I know that we at the Regenstrief Institute and Indiana University have worked very closely with our state leaders to make sure that they had the best data possible to make informed decisions about when to close down, when to open up. And when you have comprehensive data, you&rsquo;re really able to make more fine grain decisions. So, for example, in the State of Indiana, we made some reopening decisions based on county level data. So, we&rsquo;re actually able to go down to more granular levels. But I think it also helps us inform the general population in terms of their own personal decision-making. I think whether at the state level, the local level or at the individual level, having the best information possible to make the best decisions for populations, for individuals is very important. And so data, I think, is the key to that process.DocWire News: At our current pace, how long do you foresee it taking before enough Americans are vaccinated against COVID that we can return to normalcy?Dr. Shaun Grannis: So, what I see is a very impressive rollout of the vaccine and the delivery to vaccination centers. Again, we&rsquo;re tracking very closely here in Indiana. We know that we are moving the inventory of vaccines out into the vaccine centers well. So, in terms of when we think we might be able to go back to normal, first of all, I would start by saying, I don&rsquo;t think normal means returning back to the way things were before. I think that it&rsquo;s very likely that in addition to getting that annual flu shot, we likely will be getting an annual COVID vaccine as well. I also think we need to still learn what the pattern of infectivity will be with COVID. It will likely fall into the same pattern as flu, where it picks up in the fall and peaks in the early part of the year, but we still have to learn that. So, I think even though we&rsquo;re seeing light at the end of the tunnel, I think a lot of light at the end of the tunnel, we still need to gather some additional data to understand what that new normal is going to look like.There&rsquo;s still some open discussion about what percent of the population needs to be vaccinated to achieve herd immunity. Is it 60%, 70%, 80%? We certainly&nbsp; want to get the vaccine out to as many people as possible. And the other thing to consider here as well is that the vaccine has been approved for people 16 years of age and older. And they&rsquo;re beginning to do the pediatric trials at this point. The younger age group is an important constituency to develop immunity in it because they can be carriers and they can be vectors of the disease spread. And so, I&rsquo;ve heard some projections that the junior and senior high school students, the trials may be completed in time for juniors and seniors in high school to receive vaccines in the fall. Younger people receiving their vaccines in early 2022.So, we&rsquo;ve got some ways to go. I think that we are clearly increasing the herd immunity percentage in our population. But I think we still have some time to go. I would project getting back as near to previous normal as possible. Well, that will probably take us until early 2022 when the vaccine has been rolled out to the entire population.DocWire News: Any closing thoughts/remarks?Dr. Shaun Grannis: Well, I think my encouragement to everyone is if you are eligible and able to receive the vaccine, I would strongly encourage you to do so. Where there are mask mandates still in place, I would encourage people to follow that. We know that masks do help. We know that social distancing does help. We are seeing the light at the end of the tunnel, but I would encourage people to maintain vigilance, and do what they can to help slow the spread of the disease.

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Jordana Jampel

Glycan-Targeting Novel Vaccine Shows Promise for Vast Virus Protection

Infectious Disease

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Latest News

Dr. Shaun Grannis Discusses the Importance of Medical Informatics Amid the COVID-19 Pandemic

COVID-19

DocWire News recently spoke with Dr. Shaun Grannis, Vice President, Data and Analytics, Regenstrief Institute, to discuss the importance of medical informatics amid the ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe